Overview

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Status:
Unknown status

Trial end date:
2018-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the outcomes of conventionally fractionated conformal radiotherapy with CF-CRT combined with either high-dose-rate brachytherapy or stereotactic body radiotherapy for intermediate or high-risk prostate cancer patients.

Phase:

Phase 3

Details

Lead Sponsor:

Maria Sklodowska-Curie Institute - Oncology Center
Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology

Treatments:

Androgens